The analysis pinpointed which countries faced an elevated risk of spreading Zika just based on anticipated travel by athletes and delegates to the Games in Rio de Janiero.
With the 2016 Summer Olympic Games quickly approaching, there’s great concern about the threat of infection and disease transmission from the mosquito-borne Zika virus for those traveling to and from Rio de Janeiro, Brazil. However, the threat may not be as alarming as one might think.
A report issued today by the CDC found that an increased risk of Zika virus transmission as a direct result of attending the Games is unlikely, with estimated travel to the Games representing less than .25% of total travel to all Zika-affected countries. The report’s authors noted that Rio de Janeiro will be in its winter months when cooler, dryer weather generally reduces mosquito populations, which is likely to help decrease the risk of transmission.
Researchers conducted a risk assessment that studied all 206 countries participating in the Olympic Games and the number of individuals set to take part as of June 30, 2016. They assessed which countries are specifically at an increased risk for Zika transmission by employing an elimination process with 5 core qualifiers, including whether the country has a CDC travel notice, a history of the disease, or an environment that could support transmission of the disease.
Of the participating 206 countries, 39 countries have current CDC travel notices for ongoing Zika virus outbreaks or epidemics and were therefore not considered at an increased risk. Of the the remaining 167 countries without a CDC warning, 148 were also taken out of consideration for potential risk due to either the country’s history of previously having the disease or the inability of its environment to foster the disease’s transmission.
This elimination process left only 19 countries that had the potential to encounter high risk with the Zika virus. For 15 of these remaining countries that are sending athletes to Rio de Janeiro in the coming month, the study found that the risk of Zika infection would not be substantially higher than what would occur anyway, based on that country’s usual aviation travel baseline.
Therefore, the CDC research team were left with 4 countries—Chad, Djibouti, Eritrea, and Yemen—that do not have a substantial amount of travel to any country around the globe with local Zika transmission, except for their athletes’ upcoming trip to the Olympic Games. Researchers suggested that only these 4 countries of the total 206 attending the Olympic Games may be at an increased risk for Zika transmission. However, these 4 countries combined will be represented by only about 19 athletes and 60 delegates, which is a small fraction of the 350,000 to 500,000 people expected to attend the event.
“With the exception of 4 countries, attendance at the Games does not pose a unique or substantive risk for mosquito-borne transmission of Zika virus in excess of that posed by non-Games travel,” the authors wrote in the report. “Efforts to enhance global health security to prevent, detect, and respond to Zika virus, as well as other emerging infections, require a sustained international commitment at all levels of government, the private sector, and civil society.”
The authors added that individuals should still remain vigilant in protecting themselves from the virus. Pregnant women are still advised not to travel to areas with an ongoing Zika epidemic, and those attending the Games should come prepared with insect repellant and wear long sleeves and pants wherever possible.
Reference
Grills A, Morrison S, Nelson B, Miniota J, Watts A, Cetron MS. Projected zika virus importation and subsequent ongoing transmission after travel to the 2016 Olympic and Paralympic Games — Country-Specific Assessment, July 2016 [early release July 13, 2016]. MMWR. 2016; http://www.cdc.gov/mmwr/volumes/65/wr/pdfs/mm6528e1.pdf
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics
March 21st 2025Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
FDA Approves Vutrisiran to Mitigate Cardiomyopathy-Related Risks and Conditions
March 21st 2025In a recent decision, the FDA approved vutrisiran (amvuttra), making it the only approved therapy for adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) or wild-type cardiomyopathy.
Read More
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More